plerixafor
plerixafor is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand names including PLERIXAFOR, plerixafor. Available dosage forms: injection, solution, injection.
Drug Details
- Generic Name
- plerixafor
- Brand Names
- PLERIXAFOR, plerixafor
- Application Number
- ANDA208980
- Sponsor
- Patheon Manufacturing Services LLC
- NDC Codes
- 4
- Dosage Forms
- INJECTION, SOLUTION, INJECTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- PLERIXAFOR
Indications and Usage
1 INDICATIONS AND USAGE Plerixafor injection is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma (NHL) or multiple myeloma (MM). Plerixafor injection, a hematopoietic stem cell mobilizer, is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma or multiple myeloma. (1)